In vitro assessment of the inhibitory effect of goreisan extract and its ingredients on the P-glycoprotein drug transporter and cytochrome P-450 metabolic enzymes

References

• Ahn YM, Cho KW, Kang DG, Lee HS. 2012. Oryeongsan (Wulingsan), a traditional Chinese herbal medicine, induces natriuresis and diuresis along with an inhibition of the renin-angiotensin-aldosterone system in rats. J Ethnopharmacol. 141(3):780–785.
   PubMedGoogle Scholar
• Anderle P, Niederer E, Rubas W, Hilgendorf C, Spahn-Langguth H, Wunderli-Allenspach H, Merkle HP, Langguth P. 1998. P-Glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels. J Pharm Sci. 87(6):757–762.
   PubMed Web of Science ®Google Scholar
• Bailey DG, Dresser GK, Leake BF, Kim RB. 2007. Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Clin Pharmacol Ther. 81(4):495–502.
   PubMed Web of Science ®Google Scholar
• Chan WK, Nguyen LT, Miller VP, Harris RZ. 1998. Mechanism-based inactivation of human cytochrome P450 3A4 by grapefruit juice and red wine. Life Sci. 62(10):PL135–142.
   PubMed Web of Science ®Google Scholar
• Choi JS, Kang KW. 2008. Enhanced tamoxifen bioavailability after oral administration of tamoxifen in rats pretreated with naringin. Arch Pharm Res. 31(12):1631–1636.
   PubMedGoogle Scholar
• Hida M, Sadakane C, Mizuhara Y, Watanabe J, Isohama Y. 2021. Pharmacokinetics of ingredients after a single oral administration of Goreisan extraxt in rats. Jpn Pharmacol Ther. 49(6):849–860.
   Google Scholar
• Hirohashi T, Suzuki H, Chu XY, Tamai I, Tsuji A, Sugiyama Y. 2000. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2). J Pharmacol Exp Ther. 292(1):265–270.
   PubMedGoogle Scholar
• Hyuga S, Shiraishi M, Hori A, Hyuga M, Hanawa T. 2012. Effects of Kampo medicines on MDR-1-mediated multidrug resistance in human hepatocellular carcinoma HuH-7/PTX cells. Biol Pharm Bull. 35(10):1729–1739.
   PubMedGoogle Scholar
• Ito K, Satoh T, Watanabe Y, Ikarashi N, Asano T, Morita T, Sugiyama K. 2008. Effects of Kampo medicines on CYP and P-gp activity in vitro. Biol Pharm Bull. 31(5):893–896. eng.
   PubMedGoogle Scholar
• Iwanaga K, Hayashi M, Hamahata Y, Miyazaki M, Shibano M, Taniguchi M, Baba K, Kakemi M. 2010. Furanocoumarin derivatives in Kampo extract medicines inhibit cytochrome P450 3A4 and P-glycoprotein. Drug Metab Dispos. 38(8):1286–1294.
   PubMedGoogle Scholar
• Katayama K, Matsuda N, Kakuta K, Naraoka M, Takemura A, Hasegawa S, Akasaka K, Shimamura N, Itoh K, Asano K, et al. 2018. The effect of goreisan on the prevention of chronic subdural hematoma recurrence: multi-center randomized controlled study. J Neurotrauma. 35(13):1537–1542.
   PubMed Web of Science ®Google Scholar
• Komiyama S, Takeya C, Takahashi R, Yamamoto Y, Kubushiro K. 2015. Feasibility study on the effectiveness of Goreisan-based Kampo therapy for lower abdominal lymphedema after retroperitoneal lymphadenectomy via extraperitoneal approach. J Obstet Gynaecol Res. 41(9):1449–1456.
   PubMedGoogle Scholar
• Kumar A, Jaitak V. 2019. Natural products as multidrug resistance modulators in cancer. Eur J Med Chem. 176:268–291.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Kaifuchi N, Mizuhara Y, Warabi E, Watanabe J. 2018. Use of a Caco-2 permeability assay to evaluate the effects of several Kampo medicines on the drug transporter P-glycoprotein. J Nat Med. 72(4):897–904.
   PubMed Web of Science ®Google Scholar
• Ministry of Health, Labour and Welfare 2018b. Guideline on Drug Interaction for Drug Development and Appropriate Provision of Information. https://www.pmda.go.jp/files/000228122.pdf.
   Google Scholar
• Ministry of Health, Labour and Welfare 2018a. Guidance on Appropriate Medication for Elderly Patients (general). https://www.pmda.go.jp/files/000232249.pdf.
   Google Scholar
• Nakano T, Nishigami C, Irie K, Shigemori Y, Sano K, Yamashita Y, Myose T, Tominaga K, Matsuo K, Nakamura Y, et al. 2018. Goreisan prevents brain edema after cerebral ischemic stroke by inhibiting aquaporin 4 upregulation in mice. J Stroke Cerebrovasc Dis. 27(3):758–763.
   PubMed Web of Science ®Google Scholar
• Nakayama A, Tsuchiya K, Xu L, Matsumoto T, Makino T. 2022. Drug-interaction between paclitaxel and goshajinkigan extract and its constituents. J Nat Med. 76(1):59–67.
   PubMedGoogle Scholar
• Ni H, Matsumoto T, Watanabe J, Makino T. 2018. Inhibitory effect of japanese traditional kampo formula frequently prescribed in gynecological clinics on CYP3A4. Evid Based Complement Alternat Med. 2018:4259603.
   PubMedGoogle Scholar
• Ohnishi N, Nagasawa K, Yokoyama T. 2000. The verification of regulatory effects of Kampo formulations on body fluid using model mice. J Tradit Med. 17:131–136.
   Google Scholar
• Pelkonen O, Turpeinen M, Hakkola J, Honkakoski P, Hukkanen J, Raunio H. 2008. Inhibition and induction of human cytochrome P450 enzymes: current status. Arch Toxicol. 82(10):667–715.
   PubMed Web of Science ®Google Scholar
• Perloff ES, Mason AK, Dehal SS, Blanchard AP, Morgan L, Ho T, Dandeneau A, Crocker RM, Chandler CM, Boily N, et al. 2009. Validation of cytochrome P450 time-dependent inhibition assays: a two-time point IC50 shift approach facilitates kinact assay design. Xenobiotica. 39(2):99–112.
   PubMed Web of Science ®Google Scholar
• Satoh T, Watanabe Y, Ikarashi N, Ito K, Sugiyama K. 2009. Effects of Kampo medicines on P-glycoprotein. Biol Pharm Bull. 32(12):2018–2021.
   PubMedGoogle Scholar
• Taipalensuu J, Tornblom H, Lindberg G, Einarsson C, Sjoqvist F, Melhus H, Garberg P, Sjostrom B, Lundgren B, Artursson P. 2001. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther. 299(1):164–170.
   PubMed Web of Science ®Google Scholar
• Takano J, Maeda K, Bolger MB, Sugiyama Y. 2016. The prediction of the relative importance of CYP3A/P-glycoprotein to the nonlinear intestinal absorption of drugs by advanced compartmental absorption and transit model. Drug Metab Dispos. 44(11):1808–1818. doi:10.1124/dmd.116.070011.
   PubMed Web of Science ®Google Scholar
• Takeda S, Ishthara K, Wakui Y, Amagaya S, Maruno M, Akao T, Kobashi K. 1996. Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats; relevance to the intestinal bacterial hydrolysis. J Pharm Pharmacol. 48(9):902–905.
   PubMed Web of Science ®Google Scholar
• US Food Drug Administration 2020. Guidance for industry; In vitro drug interaction studies-cytochrome P450 enzyme-and transporter-mediated drug interactions. https://www.fda.gov/media/134582/download.
   Google Scholar
• van Breemen RB, Li Y. 2005. Caco-2 cell permeability assays to measure drug absorption. Expert Opin Drug Metab Toxicol. 1(2):175–185.
   PubMedGoogle Scholar
• Watanabe Y, Ikarashi N, Satoh T, Ito K, Ochiai W, Sugiyama K. 2012. Inhibitory effects of daiokanzoto (da-huang-gan-cao-tang) on p-glycoprotein. Evid Based Complement Alternat Med. 2012:361516.
   PubMedGoogle Scholar
• Yaku H, Kaneda K, Kitamura J, Kato T, Kimura T. 2021. Kampo medicine for the holistic approach to older adults with heart failure. J Cardiol. doi:10.1016/j.jjcc.2021.12.011.
   Google Scholar
• Yano Y, Yano H, Takahashi H, Yoshimoto K, Tsuda S, Fujiyama K, Izumo-Shimizu Y, Motoie R, Ito M, Tanaka J, et al. 2017. Goreisan inhibits upregulation of aquaporin 4 and formation of cerebral edema in the rat model of juvenile hypoxic-ischemic encephalopathy. Evid Based Complement Alternat Med. 2017:3209219.
   PubMedGoogle Scholar
• Yasunaga H. 2015. Effect of Japanese herbal Kampo medicine goreisan on reoperation rates after Burr-Hole surgery for chronic subdural hematoma: analysis of a national inpatient database. Evid Based Complement Alternat Med. 2015:817616.
   PubMedGoogle Scholar
• Yee S. 1997. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man–fact or myth. Pharm Res. 14(6):763–766.
   PubMed Web of Science ®Google Scholar